INTEGRATIVE PANCREATIC INTERVE

Maoquan Li is Professor in the Department of Interventional and Vascular Therapy at Shanghai Tenth People's Hospital at Tongji University. He specializes in interventional radiology. He was the first interventional radiologist in China to conduct interventional treatment of gastric cancer, adrenal tumors, embolization of uterine fibroids, rheological thrombolytic therapy, interventional comprehensive therapy for diabetic vascular disease, interventional comprehensive treatment for chronic thrombus, and the molecular targeted therapy of aesthetic liver cancer. He is a leader in the field.Ligong Lu is Chief Physician, doctoral tutor, and Dean of Zhuhai Hospital, affiliated with Tongji University. He is deputy director of the Institute of Interventional Vascular Research, and Director of the Zhuhai Intervention Centre, and the Zhuhai Precision Medical Treatment Centre. He is a doctoral tutor at Jinan University, Southern Medical University, and Guangdong Provincial Institute of Cardiovascular Disease, as well as a Professor at Macao University. He has been a senior visiting scholar at the Wayne State University Detroit Medical Center. His research focuses on basic and clinical interventional radiology, liver cancer, and malignancies.Yueyong Xiao is Deputy Director of Radiology at Shanghai Military Hospital. He is Chief Physician, and a doctoral tutor, as well as an executive member of the International Refrigeration Association, and President of the Asian Frozen Society. His work in imaging diagnosis and interventional therapy spans 30 years. He carries out CT and MRI guided minimal invasive surgery. He has been a senior visiting scholar at Harvard Medical College, specializing in CT, and MRI-guided interventional therapy.Deliang Fu is the Director of Pancreatic Surgery at Huashan hospital, affiliated with Fudan University in China, and the Director of the Pancreatic Cancer Treatment Center at Fudan University. He is also deputy director of the Institute of Pancreatic Diseases, also at Fudan University, and vice-chairman of the Pancreas Division of the Shanghai Medical Association, as well as a doctoral tutor. He has published widely in the field, both research papers and book chapters, and has led a number of National Natural Science Foundation and Ministry of Health research projects.Haijun Zhang is Director of the National Engineering Laboratory of Biomedical Material Modification Technology, and deputy director of the Institute of Interventional Vascular Research, at Tongji University in China. He is also Director of the strategic alliance for the medical material modification industry. He focuses on biomedical material modification, including in medical material engineering, medical engineering, and transformational medicine.